E

Euroapi SAS
PAR:EAPI

Watchlist Manager
Euroapi SAS
PAR:EAPI
Watchlist
Price: 3.522 EUR 3.04% Market Closed
Market Cap: 335.5m EUR
Have any thoughts about
Euroapi SAS?
Write Note

Euroapi SAS
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Euroapi SAS
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
E
Euroapi SAS
PAR:EAPI
Depreciation & Amortization
€302.9m
CAGR 3-Years
61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sanofi SA
PAR:SAN
Depreciation & Amortization
€4.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ipsen SA
PAR:IPN
Depreciation & Amortization
€147.1m
CAGR 3-Years
-14%
CAGR 5-Years
3%
CAGR 10-Years
20%
Vetoquinol SA
PAR:VETO
Depreciation & Amortization
€30.8m
CAGR 3-Years
-13%
CAGR 5-Years
16%
CAGR 10-Years
10%
Virbac SA
PAR:VIRP
Depreciation & Amortization
€49.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Medincell SA
PAR:MEDCL
Depreciation & Amortization
€1.7m
CAGR 3-Years
9%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Euroapi SAS
Glance View

Market Cap
335.5m EUR
Industry
Pharmaceuticals

EUROAPI SA operates as a manufacturer and supplier of active pharmaceutical ingredient solutions for healthcare companies. The company is headquartered in Paris, Ile-De-France and currently employs 3,342 full-time employees. The company went IPO on 2022-05-06. The firm is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc. ), analgesics, etc. The firm also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. The company has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

EAPI Intrinsic Value
4.441 EUR
Undervaluation 21%
Intrinsic Value
Price
E

See Also

What is Euroapi SAS's Depreciation & Amortization?
Depreciation & Amortization
302.9m EUR

Based on the financial report for Dec 31, 2023, Euroapi SAS's Depreciation & Amortization amounts to 302.9m EUR.

What is Euroapi SAS's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 3Y
61%

Over the last year, the Depreciation & Amortization growth was 221%. The average annual Depreciation & Amortization growth rates for Euroapi SAS have been 61% over the past three years .

Back to Top